Michelle Lavin

2.1k total citations · 2 hit papers
63 papers, 1.1k citations indexed

About

Michelle Lavin is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Michelle Lavin has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 14 papers in Genetics and 9 papers in Surgery. Recurrent topics in Michelle Lavin's work include Platelet Disorders and Treatments (35 papers), Hemophilia Treatment and Research (18 papers) and Blood groups and transfusion (14 papers). Michelle Lavin is often cited by papers focused on Platelet Disorders and Treatments (35 papers), Hemophilia Treatment and Research (18 papers) and Blood groups and transfusion (14 papers). Michelle Lavin collaborates with scholars based in Ireland, United States and Canada. Michelle Lavin's co-authors include James S. O’Donnell, Jamie M. O’Sullivan, Paula James, Rezan A. Kadir, Niamh O’Connell, Kevin M. Ryan, Mary Byrne, Peter A. Kouides, Sarah H. O’Brien and Soracha E. Ward and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Michelle Lavin

60 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

2021 181 citations Nathan T. Connell, Veronica H. Flood et al. Blood Advances profile →
The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia

2023 58 citations Peter A. Kouides, Sarah H. O’Brien et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Lavin Ireland	17	839	206	191	131	101	63	1.1k
Mohamad A. Kalot United States	10	437 0.5×	113 0.5×	127 0.7×	156 1.2×	57 0.6×	23	797
Britta A. P. Laros‐van Gorkom Netherlands	19	1.0k 1.2×	253 1.2×	177 0.9×	226 1.7×	68 0.7×	49	1.2k
Saskia E.M. Schols Netherlands	19	676 0.8×	159 0.8×	104 0.5×	109 0.8×	24 0.2×	77	1.0k
Guillermo J. Ruiz‐Delgado Mexico	17	616 0.7×	203 1.0×	65 0.3×	59 0.5×	26 0.3×	130	953
Karin P. M. van Galen Netherlands	18	691 0.8×	192 0.9×	93 0.5×	97 0.7×	41 0.4×	56	842
Karin Kurnik Germany	15	730 0.9×	130 0.6×	113 0.6×	55 0.4×	37 0.4×	31	1.0k
Victor Boulyjenkov Switzerland	8	870 1.0×	252 1.2×	157 0.8×	146 1.1×	89 0.9×	13	1.0k
Susan Halimeh Germany	17	938 1.1×	223 1.1×	92 0.5×	138 1.1×	29 0.3×	73	1.3k
Cristina Santoro Italy	21	1.2k 1.5×	501 2.4×	116 0.6×	76 0.6×	49 0.5×	106	1.5k
M. Hoffet France	14	918 1.1×	133 0.6×	82 0.4×	387 3.0×	76 0.8×	27	1.4k

Countries citing papers authored by Michelle Lavin

Since Specialization

Citations

This map shows the geographic impact of Michelle Lavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Lavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Lavin more than expected).

Fields of papers citing papers by Michelle Lavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Lavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Lavin. The network helps show where Michelle Lavin may publish in the future.

Co-authorship network of co-authors of Michelle Lavin

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Lavin. A scholar is included among the top collaborators of Michelle Lavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Lavin. Michelle Lavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atiq, Ferdows, Pamela A. Christopherson, Sandra L. Haberichter, et al.. (2025). Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program. Blood Advances. 9(19). 4780–4789. 2 indexed citations

Lassila, Riitta, Ferdows Atiq, Caterina Casari, & Michelle Lavin. (2025). Advances in Von Willebrand Disease. Haemophilia.

Clearfield, Elizabeth, Benjamin Kim, Nathan T. Connell, et al.. (2024). A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: The coreVWD initiative. Haemophilia. 30(6). 1357–1365. 3 indexed citations

Blatný, Jan, Cristina Catarino, G. Dolan, et al.. (2024). Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions. Therapeutic Advances in Hematology. 15. 1574202903–1574202903.

Kelly, Claire, et al.. (2024). Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor. Journal of Thrombosis and Haemostasis. 22(10). 2900–2909. 2 indexed citations

Miljić, Predrag, et al.. (2023). Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians’ survey—communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis. 21(1). 154–163. 3 indexed citations

Karampini, Ellie, Helen Fogarty, Colm Bergin, et al.. (2023). Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19. Research and Practice in Thrombosis and Haemostasis. 7(2). 100085–100085. 9 indexed citations

Stonebraker, Jeffrey S., Alfonso Iorio, Michelle Lavin, et al.. (2023). Reported prevalence of von Willebrand disease worldwide in relation to income classification. Haemophilia. 29(4). 975–986. 12 indexed citations

Baldwin, Maureen K., Homa K. Ahmadzia, Kristina M. Haley, et al.. (2023). Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate. Expert Review of Hematology. 16(sup1). 71–86. 9 indexed citations

10.

Grabell, Julie, Pamela A. Christopherson, Robert R. Montgomery, et al.. (2023). Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance. Journal of Thrombosis and Haemostasis. 21(4). 880–886. 15 indexed citations

11.

Lavin, Michelle, Pamela A. Christopherson, Julie Grabell, et al.. (2022). Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score. Journal of Thrombosis and Haemostasis. 20(10). 2246–2254. 5 indexed citations

12.

Othman, Maha, Geoffrey D. Barnes, Jean M. Connors, et al.. (2021). Harnessing Twitter to empower scientific engagement and communication: The ISTH 2020 virtual congress experience. Research and Practice in Thrombosis and Haemostasis. 5(2). 253–260. 6 indexed citations

13.

Lavin, Michelle, Analía Sánchez‐Luceros, Peter A. Kouides, et al.. (2021). Examining international practices in the management of pregnant women with von Willebrand disease. Journal of Thrombosis and Haemostasis. 20(1). 82–91. 11 indexed citations

14.

Worrall, Amy P, Claire Kelly, A O’Neill, et al.. (2021). Online Search Trends Influencing Anticoagulation in Patients With COVID-19: Observational Study. JMIR Formative Research. 5(8). e21817–e21817. 1 indexed citations

15.

Connell, Nathan T., Veronica H. Flood, Romina Brignardello‐Petersen, et al.. (2021). ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Advances. 5(1). 301–325. 181 indexed citations breakdown →

16.

Lavin, Michelle, et al.. (2020). The impact of foetal restrictions on mode of delivery in women with inherited bleeding disorders. European Journal Of Haematology. 105(5). 555–560. 2 indexed citations

17.

Zia, Ayesha, Peter A. Kouides, Dmitry Khodyakov, et al.. (2020). Standardizing care to manage bleeding disorders in adolescents with heavy menses—A joint project from the ISTH pediatric/neonatal and women's health SSCs. Journal of Thrombosis and Haemostasis. 18(10). 2759–2774. 16 indexed citations

18.

Lavin, Michelle, Jamie M. O’Sullivan, Kevin Ryan, et al.. (2020). Management of elective procedures in low von Willebrand factor patients in the LoVIC study. Journal of Thrombosis and Haemostasis. 19(3). 701–710. 10 indexed citations

19.

Byrne, Mary, et al.. (2018). Missed at first Glanz: Glanzmann thrombasthenia initially misdiagnosed as Von Willebrand Disease. Transfusion and Apheresis Science. 58(1). 58–60. 6 indexed citations

20.

Womack, Christopher J., Roger Strand, & Michelle Lavin. (1997). Personal paper: Disclosure of clinical audit records in law: risks and possible defences. BMJ. 315(7119). 1369–1370. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact